Beyond the Prescription Pad: Complementary and Alternative Medicine for MS

Most people living with multiple sclerosis explore complementary or alternative medicine (CAM) as part of their care. Complementary therapies—such as supplements, special diets, or mind-body practices—are used alongside disease-modifying treatments (DMTs), while alternative therapies are chosen instead of them. In this episode, we dive into commonly used CAM approaches, including anti-inflammatory and antioxidant supplements like turmeric and alpha-lipoic acid, as well as dietary strategies like the Mediterranean diet, intermittent fasting, and modified paleo.

We also explore mind-body therapies—yoga, stretching, Pilates, and meditation—that may reduce stress, enhance well-being, and even lower inflammation. Plus, we examine alternative treatments such as low-dose naltrexone (LDN), CCSVI procedures, and hyperbaric oxygen therapy, along with the potential risks of bypassing conventional care. Thoughtfully chosen and openly discussed with your healthcare team, CAM can play a meaningful supportive role in living well with MS.

This podcast episode is sponsored by TG Therapeutics.

Elizabeth Silbermann MD

Elizabeth Silbermann MD is the MS Regional Director of the VA Portland HCS* and is an Assistant Professor of Neurology at Oregon Health and Science University. She received her medical degree at Brown University and completed a residency in neurology at Washington University. She also completed a Sylvia Lawry Physician Fellowship through the National MS Society in neuroimmunology at Oregon Health and Science University at the Portland VA. She received a Masters in Clinical Research through Oregon Health & Science University.

Daniel Bandari MD

Daniel Bandari MD is the Medical Director and the Founder of the Multiple Sclerosis Center of California Clinic, Research Group and Infusion Center located in Laguna Hills, California in Orange County. He is a Clinical Assistant Professor of Neurology and Neuro-immunology and the previous director of the MS Center at the University of Southern California (USC). Dr. Bandari completed his residency in Neurology at Kaiser Permanente Medical Center in Los Angeles and his fellowship training in neuro-immunology and multiple sclerosis at USC.

*Dr. Silbermann completed this study and published results before her current position at the VA. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government.